Coronary Disease/Myocardial Infarction
RSSArticles
-
Paclitaxel-Eluting Devices: Is It Time to Stop Worrying?
Paclitaxel-eluting devices vs. bare metal stents in peripheral arterial disease showed no significant difference in all-cause mortality, contradicting the results of a controversial meta-analysis.
-
Recommendation: Less Major Surgery for Heart Valve Disease
Advancing technology creates opportunities for safer solutions, according to guideline authors.
-
Time is of the Essence with Colchicine Treatment of Myocardial Infarction
An analysis of the COLCOT study of colchicine administration after myocardial infarction (MI) showed the benefit of this therapy for preventing subsequent cardiovascular events was greatest when therapy was initiated within three days after MI onset.
-
What Causes MINOCA?
A systematic imaging protocol of coronary angiography, optical coherence tomography, and cardiac MRI in women clinically diagnosed with myocardial infarction with non-obstructive coronary artery disease revealed a cause in 84%, with three-quarters exhibiting an ischemic etiology.
-
Ticagrelor in the Elderly: More Potent Platelet Inhibition Not Always Better
In a study of 14,000 elderly patients with acute myocardial infarction, treatment with ticagrelor was associated with higher risks of bleeding and all-cause death vs. clopidogrel.
-
Which Acute Myocardial Infarction Patients Need a Blood Transfusion?
A randomized trial of a restrictive blood transfusion strategy vs. a more liberal strategy in patients with acute myocardial infarction and anemia showed the restrictive strategy is noninferior to the liberal strategy for preventing the primary outcome of death, reinfarction, stroke, or emergency revascularization.
-
Does BAMI Spell the End for Cell-Based Therapy After Acute Myocardial Infarction?
Investigators tested the mortality benefit of intracoronary bone marrow cells in patients with successfully reperfused acute myocardial infarction. They observed no effect on mortality.
-
Management of Cardiac Arrest Patients Without STEMI
Since there were no significant differences in outcomes at 90 days or one year, coronary interventions in successfully resuscitated cardiac arrest patients without evidence of STEMI or cardiogenic shock can be delayed until neurologic recovery is evident.
-
Paper: Acute Coronary Syndrome Patients are Malnourished
Nutritional interventions may be valuable for this population.
-
Thin Evidence Supporting the Obesity Paradox in STEMI
This largest-to-date analysis of six randomized studies of ST-elevation myocardial infarction revealed no association between body mass index and infarct size, one-year mortality, or heart failure hospitalization.